All Articles

Beyond flashy AI models, KOWIN's FMS 2026 showcase reveals a crucial truth: the AI revolution will be built on specialized, reliable memory.

A $150M federal loan for Niron Magnetics aims to end US reliance on foreign rare-earth magnets, fueling a new era of domestic manufacturing in Minnesota.

As Telegram evolves into a commercial titan, its ad ecosystem remains fragmented. AdsGram's new unified platform signals a play for market coherence.

A jury found the City of Vallejo retaliated against a female fire captain who reported discrimination. The resulting $5M settlement is a stark warning.

Over 2,000 essential county workers are set to strike on August 19, threatening major disruptions to public services amid a high-stakes standoff over wages.

A seventh delay in a massive debt restructuring signals deep trouble for the Paramount-WBD mega-merger, raising questions about its financial and legal viability.

Dr. David Sinclair's new Lifespan platform aims to fight aging misinformation. But can this new information infrastructure remain objective while building a brand?

Centers Health Care's attempt at a Guinness World Record is more than a PR event; it's a forensic look into the future of post-acute care and community health.

A small startup just won a $25M Air Force deal with AI that learns like a human. Can this 'lean' tech finally crack Level-5 self-driving?

The AI boom is straining power grids and water supplies. A new modular platform aims to solve this by letting data centers operate entirely off-grid.

PrintMail's new integration with Jack Henry's core systems offers a blueprint for efficiency, security, and the future of financial communication.

One Times Square, home of the Ball Drop, just spent half a billion dollars to sell you its history. But in a city of spectacles, is this a time machine or just another trap?

With at-home PCR tests and AI-driven insights, Petwealth is building a decentralized health network for pets, challenging the traditional vet care model.

A Swiss-Australian venture is bringing industrial-scale drones to the US. Their success hinges on more than just tech—it’s a test of regulatory will.

A Utah biotech's new blood test can identify the exact brain cells dying in diseases like Alzheimer's, a major leap beyond today's diagnostics.

Amid market turbulence, Andrew Farkas is forging a new powerhouse. The NAI Global deal isn't just a shuffle; it's a key move in a plan to master the downturn.

Indra’s major US transit contracts are more than just tech upgrades. They represent a calculated market entry backed by local manufacturing and high stakes.

AZIO AI Holdings is pivoting from EVs to AI infrastructure with a massive NVIDIA GPU deal. But can it navigate the financial risks to build the future?

DocHub's new 'Rooms' feature moves beyond simple PDF editing, offering a unified workspace for teams that could disrupt the competitive document management market.

With a fresh $30M and a potential $90M total, Femasys is poised to shake up women's health. But can it hit the milestones to unlock its full potential?